Cannabis
Trichome Enters into Term Sheet for $5.5 Million Secured Loan to MYM Nutraceuticals
Trichome Financial Corp. (“Trichome” or the “Company“) is pleased to announce that it has signed a non-binding Indicative Term Sheet for a $5.5 million Senior Secured Term Loan (the “Secured Loan“) to MYM Nutraceuticals Inc. (“MYM”)(CSE:MYM)(OTCBB:MYMMF). The Secured Loan will be advanced in a first tranche of $3.5 million on closing, and a conditional second tranche of $2.0 million no earlier than two months after closing. Closing of the Secured Loan is subject to MYM receiving a cultivation license from Health Canada for its facility located in Laval, Québec. The proceeds of the Secured Loan will be used by MYM to fund several growth initiatives, including its operations in Saskatchewan, Nevada, Laval and Colombia.
“We are thoroughly impressed with the level of expertise and sophistication that MYM’s new senior leadership team has displayed as they execute a pivot towards becoming leaders in all aspects of CBD-rich hemp,” said Michael Ruscetta, CEO of Trichome. “The market for our uniquely structured capital solutions to the legal cannabis sector is large and this transaction is another example of Trichome providing flexible and timely growth capital, fully secured against all the assets and licenses of MYM, which we expect will deliver extremely attractive returns.”
Secured Loan Details
The term of the Secured Loan is 12 months from the date of closing, and Trichome will have an option to extend the term by an additional 6 months. Interest will be paid monthly in cash at a rate of 12.0% per annum, and Trichome will also receive up to 5,000,000 warrants to purchase common shares of MYM as additional consideration.
The Secured Loan is secured by a first lien on MYM’s current and future tangible and intangible assets, with some exceptions. Entry into the Secured Loan is conditional upon receipt by MYM of a cultivation license from Health Canada for its facility in Laval, Québec, approval of the TSX Venture Exchange, and other conditions.
Howard Steinberg, CEO and director of MYM, is also a director of Trichome and as such has recused himself from Trichome’s board on this matter.
SOURCE Trichome Financial Corp.
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis6 days ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®1 week ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan3 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Cannabis2 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Curaleaf3 days ago
Curaleaf Completes Acquisition of Northern Green Canada